Full-Time

Associate Director

Quantitative Pharmacologist

Posted on 1/15/2025

Regeneron Pharmaceuticals

Regeneron Pharmaceuticals

10,001+ employees

Develops medicines for serious diseases

Biotechnology
Healthcare

Compensation Overview

$170.1k - $277.5kAnnually

Senior, Expert

Cambridge, MA, USA + 2 more

More locations: Berkeley Heights, NJ, USA | Tarrytown, NY, USA

Category
Physicians & Surgeons
Medical, Clinical & Veterinary
Requirements
  • PhD +6 years or MS degree +9 years in Quantitative Pharmacology (pharmacometrics) or related field
  • Hands-on usage of a broad range of quantitative tools and systems
  • Strong publication record in the field
  • Excellent interpersonal and communication skills (both written and oral)
  • Ability to communicate complex information succinctly
  • Proven experience developing QP elements of regulatory strategy and interacting with regulatory agencies without supervision
Responsibilities
  • Provide hands-on pharmacometrics support in one or more therapeutic focus areas
  • Accountable for the successful and timely completion of QP related activities
  • Develop and implement strategic analyses in support of research and development projects
  • Take accountability for the QP evaluation of a small portfolio of products or projects
  • Find opportunities for process and procedural improvements, product, or service improvements
  • Work independently, with guidance in only the most complex situations
  • Ensure analyses and documentation are of the highest quality and accuracy
Desired Qualifications
  • Strong collaborative skills and effective at building alliances across functions
  • Ability to effectively influence colleagues and multi-disciplinary project teams
  • Ability to handle all types of projects and leverage brainstorming to implement solutions for complex projects
Regeneron Pharmaceuticals

Regeneron Pharmaceuticals

View

Regeneron Pharmaceuticals develops medicines aimed at treating serious diseases such as cancer, eye diseases, and allergic conditions. The company uses its own technologies and extensive research to create new therapies, often collaborating with academic institutions and other pharmaceutical companies to enhance its development efforts. Unlike many competitors, Regeneron focuses on both research and commercialization, generating revenue through the sale of its approved medicines and licensing its technologies. The goal of Regeneron is to improve patient outcomes by providing effective treatments and ensuring that its products meet high safety and efficacy standards.

Company Stage

IPO

Total Funding

$684M

Headquarters

Town of Greenburgh, New York

Founded

1988

Simplify Jobs

Simplify's Take

What believers are saying

  • Regeneron's investment in Truveta enhances its genomic data capabilities for personalized medicine.
  • The Oxular acquisition expands Regeneron's portfolio in retinal disorder treatments.
  • Dupixent's FDA review for CSU could open a new revenue stream for Regeneron.

What critics are saying

  • Class action lawsuits may lead to financial liabilities and reputational damage.
  • Investment in Truveta may not yield expected financial returns.
  • Competition from AstraZeneca and Amgen could impact Regeneron's market share.

What makes Regeneron Pharmaceuticals unique

  • Regeneron leverages proprietary technologies for innovative treatments in serious diseases.
  • The company collaborates with academic and research institutions to enhance R&D efforts.
  • Regeneron's strategic partnerships enable shared costs and profits in new treatment development.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Wellness Program

Paid Vacation

Equity Awards

Annual Bonuses

Flexible Work Hours